A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

The EMBL-EBI search and sequence analysis tools APIs in 2019

Madeira, F., Park, Y. M., Lee, J., Buso, N., Gur, T., Madhusoodanan, N., Basutkar, P., Tivey, A. R. N., Potter, S. C., Finn, R. D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz268 · Cited by 4,167

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

Hobson, D., Curry, R. L., Beare, A. S., & Ward-Gardner, A. (1972) · Epidemiology and Infection · doi:10.1017/s0022172400022610 · Cited by 1,003

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

Yassine, H. M., Boyington, J. C., McTamney, P. M., Wei, C., Kanekiyo, M., Kong, W., Gallagher, J. R., Wang, L., Zhang, Y., Joyce, M. G., et al. (2015) · Nature Medicine · doi:10.1038/nm.3927 · Cited by 700

Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses

Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642

Advances in the development of influenza virus vaccines

Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 592

Progress in vaccine development for infectious diseases—a Keystone Symposia report

Cable, J., Graham, B. S., Koup, R. A., Seder, R. A., Karikó, K., Pardi, N., Barouch, D. H., Sharma, B., Rauch, S., Nachbagauer, R., et al. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14975 · Cited by 8

Conserved Sequence Analysis of Influenza A Virus HA Segment and Its Application in Rapid Typing

Lin, Q., Ji, X., Wu, F. Y., & Ma, L. (2021) · Diagnostics · doi:10.3390/diagnostics11081328 · Cited by 7

Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study

Youhanna, J. E., Puig‐Barberà, J., Miller, M. S., Molrine, D. C., Hadi, M., Bapat, S., Iheanacho, I., Dodman, S., Fikre, T. G., Swinburn, P., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-024-10277-4 · Cited by 6

mRNA Galsomes Vaccine Protects Budgerigars Against Virulent Chlamydia psittaci Challenge

Meyst, A. D., Mieghem, J. V., Chiers, K., Raemdonck, K., Verbeke, R., Lentacker, I., & Vanrompay, D. C. G. (2025) · Vaccines · doi:10.3390/vaccines13020206 · Cited by 7

mRNA vaccination of rabbits alters the fecundity, but not the attachment, of adult Ixodes scapularis

Matias, J., Cui, Y., Lynn, G. E., DePonte, K., Mesquita, E., Muramatsu, H., Alameh, M., Dwivedi, G., Tam, Y. K., Pardi, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50389-6 · Cited by 6

New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement

Buck, P. O., Gomes, D. A., Beck, E. C., Kirson, N. Y., Mattera, M., Carroll, S., Ultsch, B., Jayasundara, K., Uhart, M., & Garrison, L. P. (2024) · Vaccines · doi:10.3390/vaccines12030234 · Cited by 6

Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains

Zhang, W., Sloan, A. M., Prévost, J., Tamming, L. A., Raman, S. N. T., Pfeifle, A., Gravel, C., Chen, W., Hashem, A. M., Wu, J., et al. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2427792 · Cited by 6

A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection

Solodushko, V., Kim, J. H., & Fouty, B. (2025) · Gene Therapy · doi:10.1038/s41434-025-00521-0 · Cited by 5

Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread

Bull, M. B., Cohen, C. A., Leung, N., & Valkenburg, S. A. (2021) · Viruses · doi:10.3390/v13091779 · Cited by 6

Advances in nanoparticles as drug delivery systems: A review

Akomolafe, O. A., & Akinsiku, A. A. (2025) · Scientific African · doi:10.1016/j.sciaf.2025.e03101 · Cited by 6

Improved cross-protection and immunity against influenza A virus in mice using a novel mRNA vaccine with optimized design of RNA sequence

Wang, T., Han, R., Hao, Z., Cheng, X., Li, J., Zhai, C., Guo, J., Wang, D., Deng, Y., Zhang, L., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102787 · Cited by 5

Formulation-Driven Control of mRNA Polyplex Physicochemical Properties Enables Spleen-Targeted Systemic Delivery

Hori, M., Qiao, N., Yamada, K., Yum, J., Ogura, S., Uchida, S., Kim, H. J., Naito, M., & Miyata, K. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00050 · Cited by 5

Parenteral vaccine delivery

Jetha, K. L., Gogoi, N. R., Kumar, A., Shah, J. H., Trivedi, D. U., Bharadia, P. D., Vora, L. K., Valu, D., & Chavda, V. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18564-9.00004-7 · Cited by 5

Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination

Le, C. T. T., Kim, K., Raha, J. R., Bhatnagar, N., Pal, S. S., Grovenstein, P. B., Yeasmin, M., Liu, R., Wang, B., & Kang, S. (2025) · Journal of Virology · doi:10.1128/jvi.02294-24 · Cited by 5

Future prospects in mRNA vaccine development

Mbatha, L. S., Akinyelu, J., Maiyo, F., & Kudanga, T. (2023) · Biomedical Materials · doi:10.1088/1748-605x/aceceb · Cited by 7

Nanoparticle-Based Vaccines against Zoonotic Viruses: A Review

Zhang, X., & Cui, Z. (2023) · Zoonoses · doi:10.15212/zoonoses-2023-0018 · Cited by 6

Deciphering the Subtype Differentiation History of SARS-CoV-2 Based on a New Breadth-First Searching Optimized Alignment Method Over a Global Data Set of 24,768 Sequences

Lin, Q., Huang, Y., Jiang, Z., Wu, F. Y., & Ma, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.591833 · Cited by 5

Growth Hormone Accelerates Recovery From Acetaminophen-Induced Murine Liver InjuryPreprint

Everton, E., del Río-Moreno, M., Villacorta-Martín, C., Bawa, P., Lindstrom-Vautrin, J., Muramatsu, H., Rizvi, F., Smith, A. R., Tam, Y. K., Pardi, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.17.537197 · Cited by 5

Health Technology Assessment of mRNA Vaccines: Clinical, Economic, and Public Health Implications

Genovese, G., Rizzo, C. E., & Genovese, C. (2025) · Vaccines · doi:10.3390/vaccines13101045 · Cited by 4

Brief Comparison of Novel Influenza Vaccine Design Strategies

Chai, S., Ye, C., Fan, C., & Jiang, H. X. (2025) · Vaccines · doi:10.3390/vaccines13111164 · Cited by 6

Assay for rapid quantification of capped and tailed intact mRNA

Gao, R. Y., Hu, T., Taylor, A. W., Lacey, R., Thomas, K. N., McCormick, C., Miller, D. F., Rowlen, K. L., & Dawson, E. D. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127339 · Cited by 4

Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines

Hu, C., Niu, C., Li, X., He, K., Li, M., Gao, X., Wei, Q., Sun, W., Zhao, Y., Li, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1578733 · Cited by 4

A heterologous prime-boost regimen using BCG and an mRNA encoding Ag85B heightens immune response in mice

Pongma, C., Keawvilai, P., Pattarakankul, T., Rotcheewaphan, S., Alameh, M., Prompetchara, E., Premchaiporn, P., Chareanpat, P., Yindeeyoungyeon, W., Heyes, J. A., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152408 · Cited by 4

Deciphering HPAI Influenza A Virus (H5N1): Molecular Basis of Pathogenicity, Zoonotic Potential, and Advances in Vaccination Strategies

Mohammad, I., Hajelbashir, M. I., El-Bidawy, M. H., Abuderman, A., Satea, M., Arafah, A. M. R., Ansari, M. R., Rahmani, M., Warsi, M. K., Helmi, N. M., et al. (2026) · Viruses · doi:10.3390/v18040410 · Cited by 4

Tributaries of the 2023 Nobel Prize in Physiology or Medicine, and lessons learned

Pederson, T. (2023) · RNA · doi:10.1261/rna.079874.123 · Cited by 5

Rational design of an artificial tethered enzyme for non-templated post-transcriptional mRNA polyadenylation by the second generation of the C3P3 system

Boulch, M. L., Jacquet, E., Nhiri, N., Shmulevitz, M., & Jais, P. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-55947-0 · Cited by 4

Influenza B Virus Vaccine Innovation through Computational Design

Pekarek, M. J., & Weaver, E. A. (2024) · Pathogens · doi:10.3390/pathogens13090755 · Cited by 4

A single mutation at position 214 of influenza B hemagglutinin enhances cross-neutralization

Cheng, Z., Sun, Y., Shen, Y., Wu, X., Pan, L., Wu, H., Bai, Y., Zhao, C., Ma, J., & Huang, W. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2467770 · Cited by 6

Development of a virus‐based affinity ultrafiltration method for screening virus‐surface‐protein‐targeted compounds from complex matrixes: Herbal medicines as a case study

Li, Z.-Y., Li, B., Liu, M., Chen, Z., Li, P., Du, R., Su, M., Anirudhan, V., Achi, J. G., Tian, J., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29517 · Cited by 4

The type I IFN-IL-27 axis promotes mRNA vaccine-induced CD8 + T cell responsesPreprint

Phan, A. T., Aunins, E., Cruz-Morales, E., Dwivedi, G., Bunkofske, M. E., Eberhard, J. N., Aldridge, D. L., Said, H., Banda, O., Tam, Y. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633383 · Cited by 5

mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases

Tan, B. E. K., Tham, S. K., & Poh, C. L. (2025) · Viruses · doi:10.3390/v17070960 · Cited by 4

Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques

Styles, T. M., Akhtar, A., Gu, C., Neumann, G., Muramatsu, H., McPartlan, J. S., Talukder, P., Gratz, D., Stokdyk, K., Turner, H. L., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102369 · Cited by 3

A DNA vaccine based on hemagglutinin and conserved epitopes of influenza B virus provides cross-lineage protection in mice

Zhu, X., Ha, Z., Liu, S. M., Zhang, H., Zhao, W., Qiu, X., Cao, X., Wang, W., Xie, Y., Shi, N., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1645744 · Cited by 3

Comprehensive Review on Viral RNA Extraction Strategies for Enhanced Molecular Diagnostics

Artika, I. M., Ma’roef, C. N., Johar, E., Yudhaputri, F. A., & Myint, K. S. A. (2025) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/ipid/5579320 · Cited by 3

Advances and prospects of mucosal vaccination in the prevention and control of avian influenza

Hui, X., Tian, X., Ding, S., Gao, G., Gao, S., Sun, A., Zhao, T., & Wang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1766957 · Cited by 3

The Mutational Landscape of SARS-CoV-2 Variants of Concern Recovered From Egyptian Patients in 2021

Seadawy, M. G., Binsuwaidan, R., Alotaibi, B. S., El-Masry, T. A., El-Harty, B. E., Gad, A. F., Elkhatib, W. F., & El-Bouseary, M. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.923137 · Cited by 3

Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?

Sehrawat, S., Osterrieder, N., Schmid, D. S., & Rouse, B. T. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105078 · Cited by 5

An mRNA vaccine candidate encoding cholera toxin subunit B and conserved antigens of influenza viruses confers cross-protection against influenza a viruses in adult and aged mice

Xu, L., Yu, Z., Xu, Y., Wang, Q., Wang, G., Li, B., Weng, Q., Yi, Y., & Li, J. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2453304 · Cited by 3

Molecular fate-mapping of serum antibodies reveals the effects of antigenic imprinting on repeated immunizationPreprint

Schiepers, A., Wout, M. F. L. V. ’., Greaney, A. J., Zang, T. M., Muramatsu, H., Lin, P. J. C., Tam, Y. K., Mesin, L., Starr, T. N., Bieniasz, P. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.29.505743 · Cited by 3

Recombinant probiotic Escherichia coli delivers the polymeric protein of swine influenza virus for protection

Sun, J.-M., Zhang, W.-Q., Li, Y., Guo, T.-K., Zhang, R., Yang, Y.-L., Zhao, Y., Yu, L.-J., Shi, C., Yang, G., et al. (2025) · Veterinary Microbiology · doi:10.1016/j.vetmic.2025.110401 · Cited by 2

Nanotechnology in COVID-19 prevention, diagnosis, and treatment: a comprehensive review

Dilika, M. D., Syraji, Y., Jeyaramraja, P. R., Gobikanila, K., Raza, A., & Ezez, D. (2025) · Discover Nano · doi:10.1186/s11671-025-04412-6 · Cited by 2

mRNA vaccines targeting Leptospira immunoglobulin-like proteins confer partial protection in a hamster model of leptospirosis

Techawiwattanaboon, T., Leekitcharoenphon, R., Alameh, M., Boonkea, S., Sangkanjanavanich, N., Nakornpakdee, Y., Ajimathorn, Y., Prompetchara, E., Ketloy, C., Buranapraditkun, S., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.128099 · Cited by 2

Transient mRNA-based CD117 CAR T cells effectively target acute myeloid leukemia in vitro for potential use as a preconditioning strategy

Inthanachai, T., Sittplangkoon, C., Tashiro, H., Yagyu, S., Palaga, T., Tawinwung, S., & Suppipat, K. (2026) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2026.101584 · Cited by 2

mRNA Vaccines for Influenza: Hope for a Universal Vaccine?

Omotara, P., Zhu, W., & Wang, B. (2026) · BioDrugs · doi:10.1007/s40259-026-00791-z · Cited by 2

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Xiao, Q., Liu, Y., Zhang, D., Li, C., Yang, Q., Lu, D., Zhang, W., Rosenecker, J., Zou, Q., Li, Y., et al. (2022) · Journal of Visualized Experiments · doi:10.3791/64288 · Cited by 3

Experimental Animal Models for Influenza/Flu Virus Vaccine Development

Gupta, A., Satapathy, T., Pradhan, B., Sen, K., Sahu, S., Sahu, A. K., Bhardwaj, S. K., & Khan, M. A. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i2.6362 · Cited by 2

Single cell phototransfection of mRNAs encoding SARS-CoV2 spike and nucleocapsid into human astrocytes results in RNA dependent translation interference

Kim, H., Brosseau, Q., Radzio, J., Wang, J., Muramatsu, H., Kuang, D., Grady, M. S., Chen, H. I., Wolf, J. A., Ulyanova, A. V., et al. (2024) · Frontiers in Drug Delivery · doi:10.3389/fddev.2024.1359700 · Cited by 2

Critical applications and prospects of RNA modification in mRNA vaccines

Liu, C., Peng, J., Zhang, M., Xiang, H., & Yi, C. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0800 · Cited by 2

Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response

Liu, C., Ru, Y.-X., Li, H.-R., Liu, D., Liu, J., Zhao, S.-L., Wu, X., Peng, Y., Li, Y., & Deng, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142240 · Cited by 2

Vaccination COVID-19 : technologies vaccinales, efficacité en vie réelle et spécificités

Lachâtre, M., & Launay, O. (2022) · Médecine et Maladies Infectieuses Formation · doi:10.1016/j.mmifmc.2022.07.001 · Cited by 2

The Nobel Prize awarded to pioneers of mRNA vaccines

Herzog, R. W., & Giangrande, P. H. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.10.006 · Cited by 2

Drift and shape—new insights into human immunity against influenza virus neuraminidase

Fox, A. (2023) · mBio · doi:10.1128/mbio.01654-23 · Cited by 2

Intranasal hemagglutinin protein boosters induce robust mucosal immunity and cross-protection against influenza A viral challengePreprint

Moriyama, M., Rodrigues, G. R., Wang, J., Hudak, A., Dong, H., Homer, R., Weissman, D., Ma, S., & Iwasaki, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.10.616291 · Cited by 2

Immunogenicity and Protective Efficacy of a SARS-CoV-2 mRNA Vaccine Encoding Secreted Non-Stabilized Spike Protein in Mice

Prompetchara, E., Ketloy, C., Alameh, M.-G., Tarakhet, K., Kaewpang, P., Yostrerat, N., Pitakpolrat, P., Buranapraditkun, S., Manopwisedcharoen, S., Thitithanyanont, A., et al. (2022) · doi:10.1101/2022.09.07.506878 · Cited by 1

Decoding trends in mRNA vaccine research: A comprehensive bibliometric study

Zhang, C., Wang, Y., Peng, J., Wen, X., Zhang, Y., Li, K., Du, H., & Hu, X. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2355037 · Cited by 1

Genome-wide identification of characteristic nucleotide fragments for surveillance and subtype typing of influenza A viruses

Liu, J., Zhang, X., Li, S., & Ding, X. L. (2025) · Decoding Infection and Transmission · doi:10.1016/j.dcit.2025.100056 · Cited by 1

mRNA vaccine based on high-frequency prevalent antigens provides broad protection against influenza B virus

Cheng, Z., Sun, Y., Bai, Y., Wu, X., Sun, Z., Zhang, Q., Huang, W., Ma, J., & Zhao, C. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102690 · Cited by 1

In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs

Corrigan, A. R., Ngiow, S. F., Statzu, M., Albertus, A., Pampena, M. B., Nordin, J. M. L., Carro, S. D., Harper, J. L., Stammen, R. L., Wood, J., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aec3436 · Cited by 4

A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse model

Ao, Z., Vendramelli, R., Buyu, M., Trương, T., Liu, D., Gao, N., Ma, H., Amos, S., Lawrynuik, P., Nyamekye, M., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00097-26 · Cited by 1

RNA therapeutics for infectious diseases

Tu, L. M. T. P. P. L. M., Pham, T. T. D., & Than, V. T. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.01.002 · Cited by 1

RNAs in the diagnosis and treatment of major diseases

Huang, D., Zhang, T., Jiang, X., Li, J., Yan, Z., Sun, R., Su, S., & Hong, W. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0523 · Cited by 1

The Potential of mRNA Vaccines to Fight Against Viruses

Wang, X. (2024) · Viral Immunology · doi:10.1089/vim.2024.0047 · Cited by 2

mRNA疗法的研究进展与挑战

Fu, J., Feng, S., Du, B., Dong, H., Lin, J., & Yongfeng, J. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0376 · Cited by 1

Simultaneous and sequential multi-species coronavirus vaccinationPreprint

Peng, L., Fang, Z., Renauer, P. A., McNamara, A., Park, J. J.-Y., Lin, Q., Zhou, X., Dong, M. B., Zhu, B., Zhao, H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.07.491038 · Cited by 1

Current State of mRNA Vaccine Development Against Mycobacterium tuberculosis

Aernout, I., Verbeke, R., Smedt, S. C. D., Impens, F., & Lentacker, I. (2024) · Wiley eBooks · doi:10.1002/9783527838394.ch12 · Cited by 1

Vacinas baseadas em RNA mensageiro formuladas em nanopartículas lipídicas para tratamento de tumores induzidos pelo HPV-16.

da Silva, J. R. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2021.tde-17032022-102622

Modernizing the original influenza vaccine to enhance protective antibody responses against neuraminidase antigensPreprint

Martinez, M. R., Gao, J., Wan, H., Kang, H., Klenow, L., & Daniels, R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.20.529183

Recommendations for prevention of influenza A virus in children between three and five years old in China, 2022–2023

Jiang, P. (2023) · International Conference on Modern Medicine and Global Health (ICMMGH) · doi:10.1117/12.2691875

mRNA vaccine encoding neoantigen for cancer immunotherapy using mouse melanoma as a model

Sittplangkoon, C., & Palaga, T. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.23

mRNA Vaccines: A Prospective Analysis of Long-term, Multi-target, and Autoimmune DisordersPreprint

Niazi, S. K. (2023) · Preprints.org · doi:10.20944/preprints202310.1981.v1

Universal room-temperature stable influenza A nanovaccine

Siddoway, A. C. (2021) · doi:10.31274/td-20240329-849

Promising mRNA vaccine technology in combating infectious disease: a boon to futuristic game changer in medical science

Gautam, L. K., & Shukla, R. K. (2024) · The Applied Biology & Chemistry Journal · doi:10.52679/tabcj.2024.0001

Analytical Performance of a Multiplexed Microarray Assay for Rapid Identity and Quantification of a Multivalent Mrna VaccinePreprint

Gerold, M. N., Toth, E., Blair, R. H., Gao, R. Y., Nadkarni, D. V., Barua, S., Woods, J., Rowlen, K. L., & Dawson, E. D. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4849255

Changes in Characteristics of Vaccine Clinical Trial Collaboration Networks amid the COVID-19 Pandemic: Social Network Analysis

Lu, Y., Yang, X., Pan, L., Chen, J., Zhang, T., Yan, S., Xu, D., & Ouyang, Z. (2024) · International Conference on Biomedicine and Intelligent Technology (ICBIT) · doi:10.1145/3700486.3700512

Cross Protection and Sustained Immunity Against Influenza a Viruses in Mice Provided by Core-Shell Structured Lipopolyplex Delivered mRNA Vaccine with Optimized Sequences Coding HAstem-Na-Fused AntigensPreprint

Wang, T., Han, R., Hao, Z., Cheng, X., Li, J., Zhai, C., Wang, D., Deng, Y. L., Zhang, L., & Tan, W. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5083848

Peptide and m-RNA Vaccines: Peculiarities of Immunogenicity and Protective Effect

Stepanova, T. F., Trotsenko, O. E., Bakshtanovskaya, I. V., Анатольевна, Б. Е., & Stepanova, K. B. (2025) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2024-23-6-137-146

Adaptive Immunity Elicited by Vaccination

Schröder, J. (2025) · CABI eBooks · doi:10.1079/9781800625761.0005

Development Of mRNA Vaccines And Therapeutics Beyond Covid-19

Yadav, A., Dwivedi, A., & Darwhekar, G. N. (2025) · European journal of parenteral & pharmaceutical sciences · doi:10.37521/ejpps30211

How do you make a universal flu vaccine? A microbiologist explains the challenges, and how mRNA could offer a promising solution

FULLER, D. H. (2023) · doi:10.64628/aai.hv34mxq9t

The strategies and advances of mRNA translation booster

Shi, Y., Sun, K., Hu, Y., Lou, Z., Wang, Y., & You, J. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101090

mRNA-based vaccines: Rational antigen design, delivery optimization, and immune modulation

Liu, S., Shi, H., Dai, D., Tian, T., Duan, X., Sun, J., Xu, W., Yin, X., Xie, Y., & Song, X. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.112312

A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine

Werninghaus, I. C., Hinke, D. M., Katta, K., Bogen, B., & Braathen, R. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf378

COVID-19 challenges and its therapeutics

Liang, L., Li, Y., Lu, S., Wang, J., & Yao, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00024-2

Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines

Liu, R., Patterson, L. D., Yeasmin, M., Kim, K., Park, B. R., Bhatnagar, N., Raha, J. R., Grovenstein, P. B., Pal, S. S., Le, C. T. T., et al. (2026) · Virology · doi:10.1016/j.virol.2026.110884

Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines

Mishra, M., Puente‐Massaguer, E., Jones, A., Martínez-Guevara, J. L., Lai, T. Y., Abdeljawad, A., Ding, K., Zheng, N., Bournazos, S., Ravetch, J. V., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.021

Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in mice

González‐Domínguez, I., Boza, M., Abdeljawad, A., Shea, W. R., Puente‐Massaguer, E., Mishra, M., Lemus, N., Lai, T. Y., Muramatsu, H., Lam, K., et al. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102921

Development of Nanoflare Nanosensors for Monitoring Cellular Insulin mRNA in Beta Cells and Islets

Hu, Y., Zhang, Q., Tianli, H. U., Liu, J., Fu, H., Zhao, X., Yang, Z., & Xu, C. (2026) · Advanced Materials Technologies · doi:10.1002/admt.202501702

Biological Therapies: A New Frontier in Health Care

Abdel-Wahhab, M. A., Akl, E. M., El‐Nekeety, A. A., & Mehaya, F. M. (2026) · Springer eBooks · doi:10.1007/978-981-95-6378-4_4

Construction of Lipid Nanoparticles Based on Natural Molecules for Safe and Efficient mRNA Delivery

Zhong, T., Li, H., Xu, J., Zeng, F., & Wu, S. (2026) · BioNanoScience · doi:10.1007/s12668-026-02577-7

Seasonal influenza mRNA vaccine induces stronger innate and comparable or better adaptive responses than licensed inactivated vaccines

Bermúdez-Méndez, E., Lenart, K., Cerveira, R. A., Engstrand, O., Hellgren, F., Cagigi, A., Ols, S., Jasny, E., Reinhardt, A., Petsch, B., et al. (2026) · npj Vaccines · doi:10.1038/s41541-026-01492-y

mRNA vaccines against viral pathogens: molecular design, delivery systems, and clinical applications

Xu, W., Wang, J., Liu, X., Lü, M., Zhang, Z. K., & Li, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1821852

Induction of mucosal immune responses against SARS-CoV-2: a heterologous intramuscular mRNA-LNP prime/pulmonary recombinant subunit pull vaccination strategy

Ongun, M., Kola, N. S., Patel, D., Rodrigues, T. C., Schmidt, S., Lokras, A. G., Franzyk, H., Paludan, S. R., Rades, T., Thakur, A., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-60179-5

Influence of vaccine delivery route on immune imprinting in influenza vaccination

Thakkar, V., Aryan, Y., Gautam, S., Joshi, R., Kumar, S., & Joshi, D. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.129109

From Bench Curiosity to Licensed Product: The History, Science, and Clinical Translation of Messenger RNA Vaccines, with Particular Reference to Seasonal Influenza

Rao, S. (2026) · INNOVAPATH · doi:10.63501/w1mrve44

Molecular Design of Novel mRNA and Multiepitope Subunit Vaccines for H10N5 Avian Influenza A virus

Ayaz, H., Zahid, A., Zeb, A., Ahmad, F., Badar, N., Alammari, D. M., Alatawi, E. A., Ahmad, S., Alshabrmi, F. M., & Almanaa, T. N. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-11081-0

Novel EG95-based mRNA vaccines induce long-term protective immunity against echinococcosis

Chen, W.-G., Li, L., Dai, G.-D., Wu, Y.-D., Zhu, C.-G., Zhang, H., Li, X.-R., Li, L., Zhang, N., Wang, L., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014659

Towards influenza vaccine universality: Smart vaccine regimens and adjuvant-driven germinal center responses

Arsana, A., Zhu, W., Kang, S., & Wang, B. (2026) · Virology · doi:10.1016/j.virol.2026.111110

Intranasal adenoviral neuraminidase vaccine induces local and systemic immunity and homosubtypic protection against influenza A viruses

Wang, W.-C., Cao, W., Kumar, A., Mboko, W. P., Kamal, R., Sayedahmed, E. E., & Mittal, S. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1911139

mRNA vaccine encoding multimerized AIV-M2e fused to MHC-II invariant chain motif and Pan-DR epitope confers protection against H9N2 virus in chickens

Yadav, S., Varma, A., Jana, S., Mondal, S., Sharif, S., & Mallick, A. I. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.129280

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Pardi, N., Carreño, J. M., O’Dell, G., Tan, J., Bajusz, C., Muramatsu, H., Rijnink, W. F., Strohmeier, S., Loganathan, M., Bielak, D. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32149-8 · Cited by 87

Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses

McMahon, M., O’Dell, G., Tan, J., Sárközy, A., Vadovics, M., Carreño, J. M., Puente‐Massaguer, E., Muramatsu, H., Bajusz, C., Rijnink, W. F., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206333119 · Cited by 81

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

Pardi, N., Parkhouse, K., Kirkpatrick, E., McMahon, M., Zost, S. J., Mui, B. L., Tam, Y. K., Karikó, K., Barbosa, C. J., Madden, T. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05482-0 · Cited by 281

A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes

Arevalo, C. P., Bolton, M. J., Sage, V. L., Ye, N., Furey, C., Muramatsu, H., Alameh, M., Pardi, N., Drapeau, E. M., Parkhouse, K., et al. (2022) · Science · doi:10.1126/science.abm0271 · Cited by 359

The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice

Di, Y., Zhang, C., Ren, Z., Jiang, R., Tang, J., Yang, S., Wang, Z., Yu, T., Zhang, T., Yu, Z., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1483720 · Cited by 17